Intensive Care Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel.
PLoS One. 2022 May 11;17(5):e0267506. doi: 10.1371/journal.pone.0267506. eCollection 2022.
In COVID-19 patients, lung ultrasound is superior to chest radiograph and has good agreement with computerized tomography to diagnose lung pathologies. Most lung ultrasound protocols published to date are complex and time-consuming. We describe a new illustrative Point-of-care ultrasound Lung Injury Score (PLIS) to help guide the care of patients with COVID-19 and assess if the PLIS would be able to predict COVID-19 patients' clinical course.
This retrospective study describing the novel PLIS was conducted in a large tertiary-level hospital. COVID-19 patients were included if they required any form of respiratory support and had at least one PLIS study during hospitalization. Data collected included PLIS on admission, demographics, Sequential Organ Failure Assessment (SOFA) scores, and patient outcomes. The primary outcome was the need for intensive care unit (ICU) admission.
A total of 109 patients and 293 PLIS studies were included in our analysis. The mean age was 60.9, and overall mortality was 18.3%. Median PLIS score was 5.0 (3.0-6.0) vs. 2.0 (1.0-3.0) in ICU and non-ICU patients respectively (p<0.001). Total PLIS scores were directly associated with SOFA scores (inter-class correlation 0.63, p<0.001), and multivariate analysis showed that every increase in one PLIS point was associated with a higher risk for ICU admission (O.R 2.09, 95% C.I 1.59-2.75) and in-hospital mortality (O.R 1.54, 95% C.I 1.10-2.16).
The PLIS for COVID-19 patients is simple and associated with SOFA score, ICU admission, and in-hospital mortality. Further studies are needed to demonstrate whether the PLIS can improve outcomes and become an integral part of the management of COVID-19 patients.
在 COVID-19 患者中,肺部超声优于胸部 X 光,与计算机断层扫描相比具有良好的一致性,可用于诊断肺部病变。迄今为止发布的大多数肺部超声方案都很复杂且耗时。我们描述了一种新的即时超声肺损伤评分(PLIS),以帮助指导 COVID-19 患者的护理,并评估 PLIS 是否能够预测 COVID-19 患者的临床病程。
这项回顾性研究描述了一种新的 PLIS,在一家大型三级医院进行。如果患者需要任何形式的呼吸支持,并且在住院期间至少进行了一次 PLIS 研究,则将其纳入 COVID-19 患者。收集的数据包括入院时的 PLIS、人口统计学数据、序贯器官衰竭评估(SOFA)评分和患者结局。主要结局是需要入住重症监护病房(ICU)。
共纳入 109 例患者和 293 次 PLIS 研究。患者的平均年龄为 60.9 岁,总体死亡率为 18.3%。中位数 PLIS 评分为 5.0(3.0-6.0),与 ICU 和非 ICU 患者的 2.0(1.0-3.0)相比,差异有统计学意义(p<0.001)。总 PLIS 评分与 SOFA 评分直接相关(组内相关系数 0.63,p<0.001),多变量分析显示,PLIS 评分每增加 1 分,ICU 入住风险增加(OR 2.09,95%CI 1.59-2.75)和院内死亡率(OR 1.54,95%CI 1.10-2.16)。
COVID-19 患者的 PLIS 简单,与 SOFA 评分、ICU 入住和院内死亡率相关。需要进一步研究以证明 PLIS 是否可以改善结局并成为 COVID-19 患者管理的重要组成部分。